Meetings

25-09-2009

Munich, 25 September 2009

PDF file
Overview of Pre- and Post- Start-Up Programmes in Germany

Dr. Stephanie Wehnelt
BioM

Current Trends in Life Science Venture Capital

Dr. Lukas Guenther,
Wellington Partners

20-03-2009

Brussels, 20 March 2009

PDF file
The unbearable pleasures of patenting in life sciences

Dr. Sven J.R. Bostyn, LL.M.
Legal Counsel, Associate Professor of Intellectual Property Law, University of Amsterdam

PDF file
Spinning out life science research ventures: business as usual?

Paul Van Dun
General manager of K.U.Leuven Research & Development and managing director of Gemma Frisius-Fonds K.U.Leuven nv, the venture fund of the university

The Pharmaceutical Sector Inquiry: questioning the findings of the Preliminary Report

Michel Draps
Legal Counsel, Johnson & Johnson Law Department Europe

03-10-2008

Budapest, 3 October 2008

PDF file
Biotech Industry in Hungary

Mr. Ernö Duda,
Co-Founder, President & CEO of Solvo Biotechnology
Founder and President of the Hungarian Biotechnology Association

PDF file
Hungarian Healthcare System In Transition. Can A Private Service Provider Be Successful?

Mr. Gábor Kovács,
Owner of Telki Private Clinic

07-04-2008

Madrid, 7 April 2008

The Valdemoro Hospital Management Example

Juan Antonio Álvaro,
Manager of the Jiménez Díaz Foundation. Capio Group.

27-09-2007

Vienna, 27 September 2007

PDF file
Managing Patent Litigation and Intellectual Property

Daniel Alge,
Sonn & Partner, Vienna

PDF file
Biosimilar regulation in Europe and beyond

Helmut Brunar,
KWIZDA Pharma - the Austrian Life Science Company, Vienna

22-03-2007

London, 22 March 2007

The AIM market of the London Stock Exchange: advantages, statistics and listing requirements

Nick Harriss,
Director Corporate Finance
ARM Corporate Finance Limited

Thiakis Limited - a story of a successful start up biotech company in the UK

Dr. John Burt,
CEO Thiakis Limited

The Biotechnology Industry in the UK

Laura Gilbert,
Public Affairs Director
The BioIndustry Association

26-10-2006

Tel Aviv, 26 October 2006

Recent trends in the Israeli Biotechnology Industry

Mr. Gilai Dolev

Health Care Incubators

Mr. Tomer Kariv,
CEO of Pontifax Ltd and Chairman of the Board of Biomedix Incubator Ltd.

Investment in Israeli Biotech Companies and Technology

Dr. Rafi Hofstein, Ph.D.,
President and CEO Hadasit Ltd.

Management of a Biotech Company in Israel

Prof. Dror Harats, M.D.,
Chief Executive Officer-Vascular Biogenics Ltd. and Professor of Medicine, TAU

31-03-2006

Amsterdam, 31 March 2006

Creating Life Sciences Companies

Bob Smailes,
Director at Liberatis Ergo Holdings
Director Leiden Research & Innovation Services at University of Leiden
Director of Technology Transfer at Leiden University Medical Center

Promoting Life Sciences

Ginus Ipema,
Senior Policy Advisor Innovation Department of the Ministry of Economic Affairs

14-10-2005

Paris, 14 October 2005

GC for 6 months: the acquisition of TKT by Shire Pharmaceuticals

Tamara Joseph, board member LTKfarma

Overview of the biotechnologies industries in France and presentation of France Biotech actions

Angelita de Francisco, General Delegate France Biotech

11-03-2005

Madrid, 11 March 2005

Clinical Trails and Ethical Committees

Dr. Fernando S. Cassinello Plaza, MD PhD.
Anaesthesia Department. Fundación Jiménez Díaz, Madrid

Spanish Biomedical Research and Fundación Jiménez Díaz

Dr. Carmen Ayuso
Co-director Genetic department. Fundación Jiménez Díaz, Madrid.

28-05-2004

Milan, 28 May 2004

The experience of San Raffaele Biomedical Science Park

Dr. Baccanti, Director of San Raffaele Biomedical Science Park

Biotechnology companies: the current situation and their needs

Dr. Nolli, Assobiotec (Italian association of biotechnology companies) and CEO of Areta International.

23-01-2004

London, 23 January 2004

Funding of biotechnology companies: opportunities for raising money on the stock exchange

Navid Malik, Life Science Analyst Willams de Broë

Copyright © 2009-2010Biolegis | SitemapTYPO3 door Redkiwi